Advertisement

Cancer Causes & Control

, Volume 28, Issue 7, pp 699–708 | Cite as

Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES)

  • Linda E. KelemenEmail author
  • Sarah Abbott
  • Bo Qin
  • Lauren Cole Peres
  • Patricia G. Moorman
  • Kristin Wallace
  • Elisa V. Bandera
  • Jill S. Barnholtz-Sloan
  • Melissa Bondy
  • Kathleen Cartmell
  • Michele L. Cote
  • Ellen Funkhouser
  • Lisa E. Paddock
  • Edward S. Peters
  • Ann G. Schwartz
  • Paul Terry
  • Anthony J. Alberg
  • Joellen M. Schildkraut
Original paper

Abstract

Background

Smoking is a risk factor for mucinous ovarian cancer (OvCa) in Caucasians. Whether a similar association exists in African Americans (AA) is unknown.

Methods

We conducted a population-based case–control study of incident OvCa in AA women across 11 geographic locations in the US. A structured telephone interview asked about smoking, demographic, health, and lifestyle factors. Odds ratios and 95% confidence intervals (OR, 95% CI) were estimated from 613 cases and 752 controls using unconditional logistic regression in multivariable adjusted models.

Results

Associations were greater in magnitude for serous OvCa than for all OvCa combined. Compared to never smokers, increased risk for serous OvCa was observed for lifetime ever smokers (1.46, 1.11–1.92), former smokers who quit within 0–2 years of diagnosis (5.48, 3.04–9.86), and for total pack-years smoked among lifetime ever smokers (0–5 pack-years: 1.79, 1.23–2.59; >5–20 pack-years: 1.52, 1.05–2.18; >20 pack-years: 0.98, 0.61–1.56); however, we observed no dose–response relationship with increasing duration or consumption and no significant associations among current smokers. Smoking was not significantly associated with mucinous OvCa. Associations for all OvCa combined were consistently elevated among former smokers. The proportion of ever smokers who quit within 0–2 years was greater among cases (23%) than controls (7%).

Conclusions

Cigarette smoking may be associated with serous OvCa among AA, which differs from associations reported among Caucasians. Exposure misclassification or reverse causality may partially explain the absence of increased risk among current smokers and lack of dose–response associations. Better characterization of smoking patterns is needed in this understudied population.

Keywords

Cigarette smoking Racial–ethnic differences Gynecology Ovarian neoplasms Passive smoking Reverse causality 

Notes

Acknowledgments

We would like to acknowledge the AACES interviewers, Christine Bard, LaTonda Briggs, Whitney Franz (North Carolina), and Robin Gold (Detroit). We also acknowledge the individuals responsible for facilitating case ascertainment at the 11 geographic locations across the 10 study centers including Jennifer Burczyk-Brown (Alabama); Rana Bayakly and Vicki Bennett (Georgia); the Louisiana Tumor Registry; Manisha Narang (New Jersey); Diana Slone, Yingli Wolinsky, Steven Waggoner, Anne Heugel, Nancy Fusco, Kelly Ferguson, Peter Rose, Deb Strater, Taryn Ferber, Donna White, Lynn Borzi, Eric Jenison, Nairmeen Haller, Debbie Thomas, Vivian von Gruenigen, Michele McCarroll, Joyce Neading, John Geisler, Stephanie Smiddy, David Cohn, Michele Vaughan, Luis Vaccarello, Elayna Freese, James Pavelka, Pam Plummer, William Nahhas, Ellen Cato, John Moroney, Mark Wysong, Tonia Combs, Marci Bowling, Brandon Fletcher, Yingli Wolinsky (Ohio); Susan Bolick, Donna Acosta, Catherine Flanagan (South Carolina); Martin Whiteside (Tennessee) and Georgina Armstrong and the Texas Registry, Cancer Epidemiology and Surveillance Branch, Department of State Health Services.

Funding

The AACES study was funded by NCI (R01CA142081). Additional support was provided by Metropolitan Detroit Cancer Surveillance System (MDCSS) with federal funds from the National Cancer Institute, National Institute of Health, Dept. of Health and Human Services, under Contract No. HHSN261201000028C and the Epidemiology Research Core, supported in part by NCI Center Grant (P30CA22453) to the Karmanos Cancer Institute, Wayne State University School of Medicine, and NCI Center Grant (P30CA072720) to the Rutgers Cancer Institute of New Jersey. The funders had no role in the design, analysis, or writing of this article.

Compliance with ethical standards

Conflict of interest

None.

Supplementary material

10552_2017_899_MOESM1_ESM.docx (150 kb)
Supplementary material 1 (DOCX 152 kb)

References

  1. 1.
    Jamal A, Agaku IT, O’Connor E, King BA, Kenemer JB, Neff L (2014) Current cigarette smoking among adults–United States, 2005–2013. MMWR Morb Mortal Wkly Rep 63:1108–1112PubMedGoogle Scholar
  2. 2.
    U.S. Department of Health and Human Services (2014) The health consequences of smoking—50 years of progress: a report of the Surgeon General. Department of Health and Human Services. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, AtlantaGoogle Scholar
  3. 3.
    American Cancer Society (2015) Cancer facts and figures 2015. Estimated new cancer cases and deaths by sex, U.S., all sites, 2015. American Cancer Society, AtlantaGoogle Scholar
  4. 4.
    Faber MT, Kjaer SK, Dehlendorff C et al (2013) Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case−control studies. Cancer Causes Control 24:989–1004CrossRefPubMedGoogle Scholar
  5. 5.
    Collaborative Group on Epidemiological Studies of Ovarian C, Beral V, Gaitskell K et al (2012) Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol. 13:946–956CrossRefGoogle Scholar
  6. 6.
    Gram IT, Lukanova A, Brill I et al (2012) Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study. Int J Cancer 130:2204–2210CrossRefPubMedGoogle Scholar
  7. 7.
    Wentzensen N, Poole EM, Trabert B et al (2016) Ovarian cancer risk factors by histologic subtype: an analysis from the Ovarian Cancer Cohort Consortium. J Clin Oncol 34:2888–2898CrossRefPubMedGoogle Scholar
  8. 8.
    Marchbanks PA, Wilson H, Bastos E, Cramer DW, Schildkraut JM, Peterson HB (2000) Cigarette smoking and epithelial ovarian cancer by histologic type. Obstet Gynecol 95:255–260PubMedGoogle Scholar
  9. 9.
    Green A, Purdie D, Bain C, Siskind V, Webb PM (2001) Cigarette smoking and risk of epithelial ovarian cancer (Australia). Cancer Causes Control 12:713–719CrossRefPubMedGoogle Scholar
  10. 10.
    Terry PD, Miller AB, Jones JG, Rohan TE (2003) Cigarette smoking and the risk of invasive epithelial ovarian cancer in a prospective cohort study. Eur J Cancer 39:1157–1164CrossRefPubMedGoogle Scholar
  11. 11.
    Rossing MA, Cushing-Haugen KL, Wicklund KG, Weiss NS (2008) Cigarette smoking and risk of epithelial ovarian cancer. Cancer Causes Control 19:413–420CrossRefPubMedGoogle Scholar
  12. 12.
    Gram IT, Braaten T, Adami HO, Lund E, Weiderpass E (2008) Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer. Int J Cancer 122:647–652CrossRefPubMedGoogle Scholar
  13. 13.
    Baker JA, Odunuga OO, Rodabaugh KJ, Reid ME, Menezes RJ, Moysich KB (2006) Active and passive smoking and risk of ovarian cancer. Int J Gynecol Cancer 16(Suppl 1):211–218CrossRefPubMedGoogle Scholar
  14. 14.
    Goodman MT, Tung KH (2003) Active and passive tobacco smoking and the risk of borderline and invasive ovarian cancer (United States). Cancer Causes Control 14:569–577CrossRefPubMedGoogle Scholar
  15. 15.
    Cohen SS, Sonderman JS, Mumma MT, Signorello LB, Blot WJ (2011) Individual and neighborhood-level socioeconomic characteristics in relation to smoking prevalence among black and white adults in the Southeastern United States: a cross-sectional study. BMC Public Health 11:877CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Chornokur G, Amankwah EK, Schildkraut JM, Phelan CM (2013) Global ovarian cancer health disparities. Gynecol Oncol 129:258–264CrossRefPubMedGoogle Scholar
  17. 17.
    Moorman PG, Palmieri RT, Akushevich L, Berchuck A, Schildkraut JM (2009) Ovarian cancer risk factors in African-American and white women. Am J Epidemiol 170:598–606CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    John EM, Whittemore AS, Harris R, Itnyre J (1993) Characteristics relating to ovarian cancer risk: collaborative analysis of seven U.S. case–control studies. Epithelial ovarian cancer in black women. Collaborative Ovarian Cancer Group. J Natl Cancer Inst 85:142–147CrossRefPubMedGoogle Scholar
  19. 19.
    Schildkraut JM, Alberg AJ, Bandera EV et al (2014) A multi-center population-based case–control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES). BMC Cancer 14:688CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Qin B, Moorman PG, Alberg AJ et al (2016) Dietary carbohydrate intake, glycaemic load, glycaemic index and ovarian cancer risk in African–American women. Br J Nutr 115:694–702CrossRefPubMedGoogle Scholar
  21. 21.
    Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd edn. Lippincott-Reaven Publishers, PhiladelphiaGoogle Scholar
  22. 22.
    Hosmer DW, Lemeshow SL (2000) Applied logistic regression, 2nd edn. Wiley, New YorkCrossRefGoogle Scholar
  23. 23.
    Kobel M, Kalloger SE, Boyd N et al (2008) Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 5:e232CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Warren GW, Arnold SM, Valentino JP et al (2012) Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population. Radiother Oncol 103:45–48CrossRefPubMedGoogle Scholar
  25. 25.
    Morales NA, Romano MA, Michael Cummings K et al (2013) Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control 24:1223–1230CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Marquis GS, Habicht JP, Lanata CF, Black RE, Rasmussen KM (1997) Association of breastfeeding and stunting in Peruvian toddlers: an example of reverse causality. Int J Epidemiol 26:349–356CrossRefPubMedGoogle Scholar
  27. 27.
    Seidman JD, Kurman RJ, Ronnett BM (2003) Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 27:985–993CrossRefPubMedGoogle Scholar
  28. 28.
    Caraballo RS, Giovino GA, Pechacek TF et al (1998) Racial and ethnic differences in serum cotinine levels of cigarette smokers: third National Health and Nutrition Examination Survey, 1988–1991. JAMA 280:135–139CrossRefPubMedGoogle Scholar
  29. 29.
    Clark PI, Gautam S, Gerson LW (1996) Effect of menthol cigarettes on biochemical markers of smoke exposure among black and white smokers. Chest 110:1194–1198CrossRefPubMedGoogle Scholar
  30. 30.
    Murray RP, Connett JE, Buist AS, Gerald LB, Eichenhorn MS (2001) Experience of Black participants in the Lung Health Study smoking cessation intervention program. Nicotine Tob Res 3:375–382CrossRefPubMedGoogle Scholar
  31. 31.
    Mustonen TK, Spencer SM, Hoskinson RA, Sachs DP, Garvey AJ (2005) The influence of gender, race, and menthol content on tobacco exposure measures. Nicotine Tob Res 7:581–590CrossRefPubMedGoogle Scholar
  32. 32.
    Ahijevych K, Gillespie J (1997) Nicotine dependence and smoking topography among black and white women. Res Nurs Health 20:505–514CrossRefPubMedGoogle Scholar
  33. 33.
    Ahijevych KL, Tyndale RF, Dhatt RK, Weed HG, Browning KK (2002) Factors influencing cotinine half-life during smoking abstinence in African American and Caucasian women. Nicotine Tob Res 4:423–431CrossRefPubMedGoogle Scholar
  34. 34.
    Perez-Stable EJ, Herrera B, Jacob P 3rd, Benowitz NL (1998) Nicotine metabolism and intake in black and white smokers. JAMA 280:152–156CrossRefPubMedGoogle Scholar
  35. 35.
    Giovino GA, Sidney S, Gfroerer JC et al (2004) Epidemiology of menthol cigarette use. Nicotine Tob Res 6(Suppl 1):S67–S81CrossRefPubMedGoogle Scholar
  36. 36.
    Benowitz NL, Herrera B, Jacob P 3rd (2004) Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther 310:1208–1215CrossRefPubMedGoogle Scholar
  37. 37.
    Albanes D, Jones DY, Micozzi MS, Mattson ME (1987) Associations between smoking and body weight in the US population: analysis of NHANES II. Am J Public Health 77:439–444CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Olsen CM, Nagle CM, Whiteman DC et al (2013) Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocr Relat Cancer 20:251–262CrossRefPubMedGoogle Scholar
  39. 39.
    Dixon SC, Nagle CM, Thrift AP et al (2016) Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. Int J Epidemiol 45:884–895CrossRefPubMedGoogle Scholar
  40. 40.
    Marom-Haham L, Shulman A (2016) Cigarette smoking and hormones. Curr Opin Obstet Gynecol 28:230–235CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Linda E. Kelemen
    • 1
    • 2
    Email author
  • Sarah Abbott
    • 3
  • Bo Qin
    • 4
  • Lauren Cole Peres
    • 3
  • Patricia G. Moorman
    • 5
  • Kristin Wallace
    • 1
    • 2
  • Elisa V. Bandera
    • 4
  • Jill S. Barnholtz-Sloan
    • 6
  • Melissa Bondy
    • 7
  • Kathleen Cartmell
    • 8
  • Michele L. Cote
    • 9
  • Ellen Funkhouser
    • 10
  • Lisa E. Paddock
    • 11
  • Edward S. Peters
    • 12
  • Ann G. Schwartz
    • 9
  • Paul Terry
    • 13
  • Anthony J. Alberg
    • 1
    • 2
  • Joellen M. Schildkraut
    • 3
  1. 1.Department of Public Health SciencesMedical University of South CarolinaCharlestonUSA
  2. 2.Hollings Cancer CenterMedical University of South CarolinaCharlestonUSA
  3. 3.Department of Public Health SciencesUniversity of VirginiaCharlottesvilleUSA
  4. 4.Department of Population ScienceRutgers Cancer Institute of New JerseyNew BrunswickUSA
  5. 5.Department of Community and Family MedicineDuke Cancer InstituteDurhamUSA
  6. 6.Case Comprehensive Cancer CenterCase Western Reserve University School of MedicineClevelandUSA
  7. 7.Department of Medicine, Section of Epidemiology and Population SciencesBaylor College of MedicineHoustonUSA
  8. 8.College of NursingMedical University of South CarolinaCharlestonUSA
  9. 9.Department of Oncology and the Karmanos Cancer Institute, Population Studies and Disparities Research ProgramWayne State University School of MedicineDetroitUSA
  10. 10.Division of Preventive MedicineUniversity of Alabama at BirminghamBirminghamUSA
  11. 11.Cancer Surveillance Research, Rutgers Cancer Institute of New Jersey and Rutgers School of Public HealthNew Jersey State Cancer RegistryNew BrunswickUSA
  12. 12.Epidemiology ProgramLouisiana State University Health Sciences Center School of Public HealthNew OrleansUSA
  13. 13.Departments of Public Health and SurgeryUniversity of Tennessee-KnoxvilleKnoxvilleUSA

Personalised recommendations